by Elena Iemma | Jun 27, 2023 | Uncategorized
Developing biologics? EpiVax’s High Throughput Immunogenicity Assessment provides a comprehensive assessment of potential clinical immunogenicity for large sets of biologic candidates. This approach allows preclinical researchers to compare the immunogenic...